Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-02 · accession 0001680329-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-05 | PTCT | Reeve Emma | Dir | M - OptEx | $46.54 | +734 | 11.4K | +7% | +$34.2K |
| D | 2026-01-06 | 2026-01-05 | PTCT | Reeve Emma | Dir | S - Sale+OE | $76.00 | -734 | 10.7K | -6% | -$55.8K |
| D | 2026-01-06 | 2026-01-02 | PTCT | Reeve Emma | Dir | A - Grant | $0.00 | +4,000 | 10.7K | +60% | $0 |
| D | 2026-01-06 | 2026-01-02 | PTCT | Reeve Emma | Dir | A - Grant | $0.00 | +3,475 | 3,475 | New | $0 |
| D | 2026-01-06 | 2026-01-05 | PTCT | Reeve Emma | Dir | M - OptEx | $0.00 | -734 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-05 | M | A | 734 | $46.54 | 11,400 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-05 | S | D | 734 | $76.00 | 10,666 | D | — | — | |
| 3 | Common | Common Stock | 2026-01-02 | A | A | 4,000 | $0.00 | 10,666 | D | — | — | (F1) Restricted stock units granted on January 2, 2026 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 2, 2026 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 2, 2027. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-01-02 | A | A | 3,475 | $0.00 | 3,475 | D | $76.74 · — to 2036-01-01 | 3,475 Common Stock | (F3) This option was granted on January 2, 2026 and vests over one year in twelve equal monthly installments, commencing on February 2, 2026. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-01-05 | M | D | 734 | $0.00 | 0 | D | $46.54 · — to 2035-01-02 | 734 Common Stock | (F4) Currently exercisable. |